4D Molecular Therapeutics (FDMT) Other Non Operating Income (2020 - 2025)
Historic Other Non Operating Income for 4D Molecular Therapeutics (FDMT) over the last 6 years, with Q3 2025 value amounting to -$21000.0.
- 4D Molecular Therapeutics' Other Non Operating Income fell 200000.0% to -$21000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$36000.0, marking a year-over-year increase of 4626.87%. This contributed to the annual value of -$77000.0 for FY2024, which is 5745.86% up from last year.
- According to the latest figures from Q3 2025, 4D Molecular Therapeutics' Other Non Operating Income is -$21000.0, which was down 200000.0% from -$61000.0 recorded in Q2 2025.
- In the past 5 years, 4D Molecular Therapeutics' Other Non Operating Income ranged from a high of $67000.0 in Q1 2025 and a low of -$158000.0 during Q3 2023
- Its 5-year average for Other Non Operating Income is -$25117.6, with a median of -$13000.0 in 2021.
- Over the last 5 years, 4D Molecular Therapeutics' Other Non Operating Income had its largest YoY gain of 77000.0% in 2025, and its largest YoY loss of 200000.0% in 2025.
- Quarter analysis of 5 years shows 4D Molecular Therapeutics' Other Non Operating Income stood at -$7000.0 in 2021, then soared by 142.86% to $3000.0 in 2022, then tumbled by 466.67% to -$11000.0 in 2023, then tumbled by 90.91% to -$21000.0 in 2024, then changed by 0.0% to -$21000.0 in 2025.
- Its Other Non Operating Income stands at -$21000.0 for Q3 2025, versus -$61000.0 for Q2 2025 and $67000.0 for Q1 2025.